BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grohskopf LA, Alyanak E, Broder KR, Blanton LH, Fry AM, Jernigan DB, Atmar RL. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season. MMWR Recomm Rep 2020;69:1-24. [PMID: 32820746 DOI: 10.15585/mmwr.rr6908a1] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 36.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin C, Chang C, Yeh C, Chang Y, Chen T, Liao C. Outcomes following diabetes admission in patients who had influenza vaccination: a population-based cohort study. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109930] [Reference Citation Analysis]
2 Ferdinands JM, Patel M. Influence of disease attenuation on relative influenza vaccine effectiveness by vaccine type. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.03.012] [Reference Citation Analysis]
3 Choi MJ, Shin G, Kang D, Lim J, Kim Y, Choi WS, Yun J, Noh JY, Song JY, Kim WJ, Choi S, Cheong HJ. Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years. Vaccines 2022;10:445. [DOI: 10.3390/vaccines10030445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Regan AK, Munoz FM. Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunization. Expert Rev Vaccines 2021;20:649-60. [PMID: 33832397 DOI: 10.1080/14760584.2021.1915138] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hughes K, Middleton DB, Nowalk MP, Balasubramani GK, Martin ET, Gaglani M, Talbot HK, Patel MM, Ferdinands JM, Zimmerman RK, Silveira FP; HAIVEN Study Investigators. Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults. Clin Infect Dis 2021:ciaa1927. [PMID: 33388741 DOI: 10.1093/cid/ciaa1927] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Zhao L, Young K, House A, Stirling R, Tunis M. Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada's experience with the live-attenuated influenza vaccine. Can Commun Dis Rep 2021;47:279-84. [PMID: 34220353 DOI: 10.14745/ccdr.v47i56a06] [Reference Citation Analysis]
7 Ortiz JR, Yu SL, Driscoll AJ, Williams SR, Robertson J, Hsu JS, Chen WH, Biellik RJ, Sow S, Kochhar S, Neuzil KM. The operational feasibility of vaccination programs targeting influenza risk groups in the WHO African and South-East Asian Regions. Clin Infect Dis 2021:ciab393. [PMID: 33949661 DOI: 10.1093/cid/ciab393] [Reference Citation Analysis]
8 Mason A, Anver H, Lwin M, Holroyd C, Faust SN, Edwards CJ. Lupus, vaccinations and COVID-19: What we know now. Lupus 2021;:9612033211024355. [PMID: 34134555 DOI: 10.1177/09612033211024355] [Reference Citation Analysis]
9 Hofstetter AM, Opel DJ, Stockwell MS, Hsu C, Zhou C, Mangione-Smith RM, Englund JA. Associations Between Health Care Professional Communication Practices and Influenza Vaccination of Hospitalized Children. Acad Pediatr 2021;21:1142-50. [PMID: 34217901 DOI: 10.1016/j.acap.2021.06.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, Albuquerque A, Allocca M, Esteve M, Farraye FA, Gordon H, Karmiris K, Kopylov U, Kirchgesner J, MacMahon E, Magro F, Maaser C, de Ridder L, Taxonera C, Toruner M, Tremblay L, Scharl M, Viget N, Zabana Y, Vavricka S. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis 2021;15:879-913. [PMID: 33730753 DOI: 10.1093/ecco-jcc/jjab052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
11 Menezes AMB, Hallal PC, Silveira MF, Wehrmeister FC, Horta BL, Barros AJD, Hartwig FP, Oliveira PD, Vidaletti LP, Mesenburg MA, Jacques N, Barros FC, Victora CG. Influenza vaccination in older adults during the COVID-19 pandemic: a population-based study in 133 Brazilian cities. Cien Saude Colet 2021;26:2937-47. [PMID: 34378687 DOI: 10.1590/1413-81232021268.09382021] [Reference Citation Analysis]
12 Sanz-Rojo S, Jiménez-García R, López-de-Andrés A, de Miguel-Diez J, Perez-Farinos N, Zamorano-León JJ. Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020. Vaccine 2021;39:7012-20. [PMID: 34742593 DOI: 10.1016/j.vaccine.2021.10.059] [Reference Citation Analysis]
13 Sekiya T, Ohno M, Nomura N, Handabile C, Shingai M, Jackson DC, Brown LE, Kida H. Selecting and Using the Appropriate Influenza Vaccine for Each Individual. Viruses 2021;13:971. [PMID: 34073843 DOI: 10.3390/v13060971] [Reference Citation Analysis]
14 Lee YJ, Kim SE, Park YE, Chang JY, Song HJ, Kim DH, Yang YJ, Kim BC, Lee JG, Yang HC, Choi M, Myung SJ; Clinical Practice Guideline Committee of the Korean Association for the Study of the Intestinal Diseases. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID]. Korean J Gastroenterol 2021;78:117-28. [PMID: 34446634 DOI: 10.4166/kjg.2021.110] [Reference Citation Analysis]
15 Atyeo C, DeRiso EA, Davis C, Bordt EA, De Guzman RM, Shook LL, Yonker LM, Fasano A, Akinwunmi B, Lauffenburger DA, Elovitz MA, Gray KJ, Edlow AG, Alter G. COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women. Sci Transl Med 2021;13:eabi8631. [PMID: 34664972 DOI: 10.1126/scitranslmed.abi8631] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hill HA, Yankey D, Elam-Evans LD, Singleton JA, Pingali SC, Santibanez TA. Vaccination Coverage by Age 24 Months Among Children Born in 2016 and 2017 - National Immunization Survey-Child, United States, 2017-2019. MMWR Morb Mortal Wkly Rep 2020;69:1505-11. [PMID: 33090985 DOI: 10.15585/mmwr.mm6942a1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
17 Manley HJ, Lacson EK, Aweh G, Li NC, Weiner DE, Miskulin DC, Hsu CM, Kapoian T, Hayney MS, Meyer KB, Johnson DS. Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients. American Journal of Kidney Diseases 2022. [DOI: 10.1053/j.ajkd.2022.01.425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hauge SH, de Blasio BF, Håberg SE, Oakley L. Influenza hospitalizations during childhood in children born preterm. Influenza Other Respir Viruses 2021. [PMID: 34519431 DOI: 10.1111/irv.12908] [Reference Citation Analysis]
19 Allen JD, Ross TM. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019. J Virol 2022;:e0165221. [PMID: 35289635 DOI: 10.1128/jvi.01652-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Shinjoh M, Furuichi M, Kobayashi H, Yamaguchi Y, Maeda N, Yaginuma M, Kobayashi K, Nogayama T, Chiga M, Oshima M, Kuramochi Y, Yamada G, Narabayashi A, Ookawara I, Nishida M, Tsunematsu K, Kamimaki I, Shimoyamada M, Yoshida M, Shibata A, Nakata Y, Taguchi N, Mitamura K, Takahashi T. Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.04.033] [Reference Citation Analysis]
21 Shapiro JR, Li H, Morgan R, Chen Y, Kuo H, Ning X, Shea P, Wu C, Merport K, Saldanha R, Liu S, Abrams E, Chen Y, Kelly DC, Sheridan-Malone E, Wang L, Zeger SL, Klein SL, Leng SX. Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults. NPJ Vaccines 2021;6:147. [PMID: 34887436 DOI: 10.1038/s41541-021-00412-6] [Reference Citation Analysis]
22 Sovann L, Sar B, Kab V, Yann S, Kinzer M, Raftery P, Albalak R, Patel S, Hay PL, Seng H, Um S, Chin S, Chau D, Khalakdina A, Karlsson E, Olsen S, Mott J. An influenza A (H3N2) virus outbreak in the Kingdom of Cambodia during the COVID-19 pandemic of 2020. International Journal of Infectious Diseases 2021;103:352-7. [DOI: 10.1016/j.ijid.2020.11.178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Griffin G, Cunningham B, Beary JM, Spolter Y, Gandee R, Newey CR. Lighting Strikes Twice: Recurrent Guillain-Barré Syndrome (GBS) after Influenza Vaccination. Case Rep Neurol Med 2021;2021:6690643. [PMID: 33614175 DOI: 10.1155/2021/6690643] [Reference Citation Analysis]
24 Peacock G, Ryerson AB, Koppaka R, Tschida J. The importance of seasonal influenza vaccination for people with disabilities during the COVID-19 pandemic. Disabil Health J 2021;14:101058. [PMID: 33384278 DOI: 10.1016/j.dhjo.2020.101058] [Reference Citation Analysis]
25 Freedman MS, Ault K, Bernstein H. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2021. MMWR Morb Mortal Wkly Rep 2021;70:193-6. [PMID: 33571173 DOI: 10.15585/mmwr.mm7006a2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
26 Chu A, Gupta V, Unni EJ. Utilizing the Theory of Planned Behavior to determine the intentions to receive the influenza vaccine during COVID-19: A cross-sectional survey of US adults. Prev Med Rep 2021;23:101417. [PMID: 34094818 DOI: 10.1016/j.pmedr.2021.101417] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Hsia J, Zhao G, Lu PJ, Town M. Estimating bias from internet non-use for a hybrid web vaccination survey - 2013-2017 Behavioral Risk Factor Surveillance System. Vaccine 2021;39:4160-5. [PMID: 34127295 DOI: 10.1016/j.vaccine.2021.05.080] [Reference Citation Analysis]
28 Otero-Romero S, Sánchez-Montalvá A, Vidal-Jordana A. Assessing and mitigating risk of infection in patients with multiple sclerosis on disease modifying treatment. Expert Rev Clin Immunol 2021;17:285-300. [PMID: 33543657 DOI: 10.1080/1744666X.2021.1886924] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Machado MAA, Moura CS, Abrahamowicz M, Ward BJ, Pilote L, Bernatsky S. Relative effectiveness of influenza vaccines in elderly persons in the United States, 2012/2013-2017/2018 seasons. NPJ Vaccines 2021;6:108. [PMID: 34429431 DOI: 10.1038/s41541-021-00373-w] [Reference Citation Analysis]
30 Boccalini S, Bechini A, Moscadelli A, Paoli S, Schirripa A, Bonanni P. Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review. Expert Rev Pharmacoecon Outcomes Res 2021;:1-12. [PMID: 33930994 DOI: 10.1080/14737167.2021.1925110] [Reference Citation Analysis]
31 Allen J, Zareen Z, Doyle S, Whitla L, Afzal Z, Stack M, Franklin O, Green A, James A, Leahy TR, Quinn S, Elnazir B, Russell J, Paran S, Kiely P, Roche EF, McDonnell C, Baker L, Hensey O, Gibson L, Kelly S, McDonald D, Molloy EJ. Multi-Organ Dysfunction in Cerebral Palsy. Front Pediatr 2021;9:668544. [PMID: 34434904 DOI: 10.3389/fped.2021.668544] [Reference Citation Analysis]
32 Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota J, Kawana A, Izumikawa K, Kikuchi T, Ohmagari N, Yamada M, Maruyama T, Takazono T, Miki M, Miyazaki Y, Yamazaki Y, Kakeya H, Ogawa K, Nagai H, Watanabe A. Clinical manifestations of hospitalized influenza patients without risk factors: A prospective multicenter cohort study in Japan via internet surveillance. Journal of Infection and Chemotherapy 2022. [DOI: 10.1016/j.jiac.2022.02.001] [Reference Citation Analysis]
33 Nilsson NH, Bendix M, Öhlund L, Widerström M, Werneke U, Maripuu M. Increased Risks of Death and Hospitalization in Influenza/Pneumonia and Sepsis for Individuals Affected by Psychotic Disorders, Bipolar Disorders, and Single Manic Episodes: A Retrospective Cross-Sectional Study. J Clin Med 2021;10:4411. [PMID: 34640430 DOI: 10.3390/jcm10194411] [Reference Citation Analysis]
34 Shin G, Kang D, Cheong HJ, Choi SE. Cost-Effectiveness of Extending the National Influenza Vaccination Program in South Korea: Does Vaccination of Older Adults Provide Health Benefits to the Entire Population? Vaccines (Basel) 2022;10:932. [PMID: 35746540 DOI: 10.3390/vaccines10060932] [Reference Citation Analysis]
35 Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, Kniss K, Burns E, Rowe T, Foust A, Jasso G, Merced-Morales A, Davis CT, Jang Y, Jones J, Daly P, Gubareva L, Barnes J, Kondor R, Sessions W, Smith C, Wentworth DE, Garg S, Havers FP, Fry AM, Hall AJ, Brammer L, Silk BJ. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021. Am J Transplant 2021;21:3481-6. [PMID: 34624182 DOI: 10.1111/ajt.16049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
36 Jabr Alwazzeh M, Mohammed Telmesani L, Saud AlEnazi A, Abdulwahab Buohliqah L, Talal Halawani R, Jatoi NA, Subbarayalu AV, Abdulaziz Almuhanna F. Seasonal influenza vaccination coverage and its association with COVID-19 in Saudi Arabia. Inform Med Unlocked 2021;27:100809. [PMID: 34869828 DOI: 10.1016/j.imu.2021.100809] [Reference Citation Analysis]
37 Liprandi ÁS, Liprandi MIS, Zaidel EJ, Aisenberg GM, Baranchuk A, Barbosa ECD, Sánchez GB, Alexander B, Zanetti FTL, Santi RL, Múnera-Echeverri AG, Perel P, Piskorz D, Ruiz-Mori CE, Saucedo J, Valdez O, Juanatey JRG, Piñeiro DJ, Pinto FJ, Quintana FSW. Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation. Glob Heart 2021;16:55. [PMID: 34381676 DOI: 10.5334/gh.1069] [Reference Citation Analysis]
38 Handabile C, Sekiya T, Nomura N, Ohno M, Kawakita T, Shingai M, Kida H. Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection. Vaccines 2022;10:804. [DOI: 10.3390/vaccines10050804] [Reference Citation Analysis]
39 Chen C, Lin C, Chiu C, Yang TY, Hsu M, Wang Y, Lei M, Yeh HT, Fang Y, Hao W, Liu J. Influenza Vaccination and Risk of Stroke in Women With Chronic Obstructive Pulmonary Disease: A Nationwide, Population-Based, Propensity-Matched Cohort Study. Front Med 2022;9:811021. [DOI: 10.3389/fmed.2022.811021] [Reference Citation Analysis]
40 Stephenson PL, Taylor MV. Vaccination for Influenza - Consumer Health Information. Journal of Consumer Health on the Internet 2021;25:319-30. [DOI: 10.1080/15398285.2021.1953340] [Reference Citation Analysis]
41 Jennewein MF, Kosikova M, Noelette FJ, Radvak P, Boudreau CM, Campbell JD, Chen WH, Xie H, Alter G, Pasetti MF. Functional and structural modifications of influenza antibodies during pregnancy. iScience 2022;25:104088. [PMID: 35402869 DOI: 10.1016/j.isci.2022.104088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Chervenak FA, McCullough LB, Grünebaum A. Reversing physician hesitancy to recommend COVID-19 vaccination for pregnant patients. Am J Obstet Gynecol 2022;226:805-12. [PMID: 34762864 DOI: 10.1016/j.ajog.2021.11.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Takano T, Hirose M, Yamasaki Y, Hara M, Okada T, Kunishima H. Investigation of the incidence of immunisation stress-related response following COVID-19 vaccination in healthcare workers. Journal of Infection and Chemotherapy 2022. [DOI: 10.1016/j.jiac.2022.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Stafford IA, Parchem JG, Sibai BM. The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations. Am J Obstet Gynecol 2021;224:484-95. [PMID: 33529575 DOI: 10.1016/j.ajog.2021.01.022] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 45.0] [Reference Citation Analysis]
45 Seo J, Lim J. The impact of free vaccination policies under the Korean Influenza National Immunization Program: Trends in influenza vaccination rates in South Korea from 2010 to 2019. PLoS One 2022;17:e0262594. [PMID: 35051210 DOI: 10.1371/journal.pone.0262594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Kennedy RB, Ovsyannikova IG, Poland GA. Update on Influenza Vaccines: Needs and Progress. J Allergy Clin Immunol Pract 2021;9:3599-603. [PMID: 34416408 DOI: 10.1016/j.jaip.2021.08.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Kamidani S, Garg S, Rolfes MA, Campbell AP, Cummings CN, Haston JC, Openo KP, Fawcett E, Chai SJ, Herlihy R, Yousey-Hindes K, Monroe ML, Kim S, Lynfield R, Smelser C, Muse A, Felsen CB, Billing L, Thomas A, Talbot HK, Schaffner W, Risk I, Anderson EJ. Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in U.S. Children Over 9 Seasons Following the 2009 H1N1 Pandemic. Clin Infect Dis 2022:ciac296. [PMID: 35438769 DOI: 10.1093/cid/ciac296] [Reference Citation Analysis]
48 Ferrigno B, Mukamal K. Risk-Taking Behaviors and the Likelihood of Influenza Vaccination: a Nationwide Analysis of the Behavioral Risk Factor Surveillance System. J Gen Intern Med 2022. [PMID: 35915294 DOI: 10.1007/s11606-022-07723-x] [Reference Citation Analysis]
49 Simionescu AA, Streinu-Cercel A, Popescu FD, Stanescu AMA, Vieru M, Danciu BM, Miron VD, Săndulescu O. Comprehensive Overview of Vaccination during Pregnancy in Europe. J Pers Med 2021;11:1196. [PMID: 34834548 DOI: 10.3390/jpm11111196] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Vijayan V. Vaccines for International Pediatric Travelers. Pediatr Clin North Am 2022;69:171-84. [PMID: 34794673 DOI: 10.1016/j.pcl.2021.08.009] [Reference Citation Analysis]
51 Kaur R, Callaghan T, Regan AK. Disparities in Prenatal Immunization Rates in Rural and Urban US Areas by Indicators of Access to Care. The Journal of Rural Health. [DOI: 10.1111/jrh.12647] [Reference Citation Analysis]
52 Razzaghi H, Kahn KE, Black CL, Lindley MC, Jatlaoui TC, Fiebelkorn AP, Havers FP, D'Angelo DV, Cheung A, Ruther NA, Williams WW. Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2020. MMWR Morb Mortal Wkly Rep 2020;69:1391-7. [PMID: 33001873 DOI: 10.15585/mmwr.mm6939a2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
53 Girerd N, Chapet N, Roubille C, Roncalli J, Salvat M, Mouquet F, Lamblin N, Gueffet JP, Damy T, Galinier M, Tartiere JM, Janssen C, Berthelot E, Aguilhon S, Escamilla R, Roubille F. Vaccination for Respiratory Infections in Patients with Heart Failure. J Clin Med 2021;10:4311. [PMID: 34640328 DOI: 10.3390/jcm10194311] [Reference Citation Analysis]
54 Malosh RE, Petrie JG, Callear A, Truscon R, Johnson E, Evans R, Bazzi L, Cheng C, Thompson MS, Martin ET, Monto AS. Effectiveness of Influenza Vaccines in the HIVE household cohort over 8 years: is there evidence of indirect protection? Clin Infect Dis 2021:ciab395. [PMID: 33949666 DOI: 10.1093/cid/ciab395] [Reference Citation Analysis]
55 Bandell A, Ambrose CS, Maniaci J, Wojtczak H. Safety of live attenuated influenza vaccine (LAIV) in children and adults with asthma: a systematic literature review and narrative synthesis. Expert Rev Vaccines 2021;:1-12. [PMID: 33939928 DOI: 10.1080/14760584.2021.1925113] [Reference Citation Analysis]
56 Michos ED, Udell JA. Am I Getting the Influenza Shot Too?: Influenza Vaccination as Post-Myocardial Infarction Care for the Prevention of Cardiovascular Events and Death. Circulation 2021;144:1485-8. [PMID: 34723637 DOI: 10.1161/CIRCULATIONAHA.121.057534] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Heintzman J, Hwang J, Quiñones AR, Guzman CEV, Bailey SR, Lucas J, Giebultowicz S, Chan B, Marino M. Influenza and pneumococcal vaccination delivery in older Hispanic populations in the United States. J Am Geriatr Soc 2021. [PMID: 34854478 DOI: 10.1111/jgs.17589] [Reference Citation Analysis]
58 Yu Y, Ma Y, Luo S, Wang S, Zhao J, Zhang G, Li L, Li L, Tak-fai Lau J. Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.04.077] [Reference Citation Analysis]
59 Jones WA, Castro RC, Masters HL 3rd, Carrico R. Influenza Management During the COVID-19 Pandemic: A Review of Recent Innovations in Antiviral Therapy and Relevance to Primary Care Practice. Mayo Clin Proc Innov Qual Outcomes 2021;5:974-91. [PMID: 34414356 DOI: 10.1016/j.mayocpiqo.2021.07.005] [Reference Citation Analysis]
60 Daley MF, Reifler LM, Shoup JA, Glanz JM, Naleway AL, Jackson ML, Hambidge SJ, Mclean H, Kharbanda EO, Klein NP, Lewin BJ, Weintraub ES, Mcneil MM, Razzaghi H, Singleton JA. Influenza Vaccination Among Pregnant Women: Self-report Compared With Vaccination Data From Electronic Health Records, 2018-2020 Influenza Seasons. Public Health Rep. [DOI: 10.1177/00333549221099932] [Reference Citation Analysis]
61 Kalnin KV, Plitnik T, Kishko M, Huang D, Raillard A, Piolat J, Anosova NG, Tibbitts T, DiNapoli J, Karve S, Goldman R, Gopani H, Dias A, Tran K, Zacharia M, Gu X, Boeglin L, Abysalh J, Vargas J, Beaulieu A, Shah M, Jeannotte T, Gillis K, Chivukula S, Swearingen R, Landolfi V, Fu TM, DeRosa F, Casimiro D. Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model. Vaccine 2022;40:1289-98. [PMID: 35101265 DOI: 10.1016/j.vaccine.2022.01.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Chen CC, Lin CH, Hao WR, Yeh JS, Chiang KH, Fang YA, Chiu CC, Yang TY, Wu YW, Liu JC. Influenza Vaccination and the Risk of Ventricular Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease: A Population-Based Longitudinal Study. Front Cardiovasc Med 2021;8:731844. [PMID: 34722665 DOI: 10.3389/fcvm.2021.731844] [Reference Citation Analysis]
63 Kaur R, Callaghan T, Regan AK. Disparities in maternal influenza immunization among women in rural and urban areas of the United States. Prev Med 2021;147:106531. [PMID: 33771563 DOI: 10.1016/j.ypmed.2021.106531] [Reference Citation Analysis]
64 Kromer C, Wellmann P, Siemer R, Klein S, Mohr J, Pinter A, Wilsmann-Theis D, Mössner R. Influenza Vaccination in Psoriatic Patients-Epidemiology and Patient Perceptions: A German Multicenter Study (Vac-Pso). Vaccines (Basel) 2021;9:843. [PMID: 34451968 DOI: 10.3390/vaccines9080843] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Friedman MA, Curtis JR, Winthrop KL. Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases. Ann Rheum Dis 2021;80:1255-65. [PMID: 34493491 DOI: 10.1136/annrheumdis-2021-221244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 de St Maurice A, Martin-Blais R, Halasa N. Preparing for the 2020-2021 influenza season. Pediatr Transplant 2021;25:e14025. [PMID: 33904211 DOI: 10.1111/petr.14025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Tripp RA, Martin DE. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication. Viruses 2022;14:612. [DOI: 10.3390/v14030612] [Reference Citation Analysis]
68 Hadler JL. Will Severe Acute Respiratory Syndrome Coronavirus 2 Prevention Efforts Affect the Coming Influenza Season in the United States and Northern Hemisphere? J Infect Dis 2020;222:1759-61. [PMID: 32894862 DOI: 10.1093/infdis/jiaa571] [Reference Citation Analysis]
69 Jagielska AM, Brydak LB, Nitsch-Osuch AS. Immunogenicity of Split Inactivated Quadrivalent Influenza Vaccine in Adults with Obesity in the 2017/2018 Season. Med Sci Monit 2021;27:e929572. [PMID: 33994536 DOI: 10.12659/MSM.929572] [Reference Citation Analysis]
70 Schmader KE, Liu CK, Harrington T, Rountree W, Auerbach H, Walter EB, Barnett ED, Schlaudecker EP, Todd CA, Poniewierski M, Staat MA, Wodi P, Broder KR. Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial. JAMA Netw Open 2021;4:e2031266. [PMID: 33443580 DOI: 10.1001/jamanetworkopen.2020.31266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Behrouzi B, Udell JA. Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination. Curr Atheroscler Rep 2021;23:78. [PMID: 34671861 DOI: 10.1007/s11883-021-00973-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Yokomizo S, Katagiri W, Maki Y, Sano T, Inoue K, Fukushi M, Atochin DN, Kushibiki T, Kawana A, Kimizuka Y, Kashiwagi S. Brief exposure of skin to near-infrared laser augments early vaccine responses. Nanophotonics 2021;10:3187-97. [PMID: 34868804 DOI: 10.1515/nanoph-2021-0133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 Delgado-Hernández B, Mugica L, Acosta M, Pérez F, Montano DLN, Abreu Y, Ayala J, Percedo MI, Alfonso P. Knowledge, Attitudes, and Risk Perception Toward Avian Influenza Virus Exposure Among Cuban Hunters. Front Public Health 2021;9:644786. [PMID: 34368040 DOI: 10.3389/fpubh.2021.644786] [Reference Citation Analysis]
74 Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, Cohen C, Fry AM. Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1305-1309. [PMID: 32941415 DOI: 10.15585/mmwr.mm6937a6] [Cited by in Crossref: 127] [Cited by in F6Publishing: 129] [Article Influence: 63.5] [Reference Citation Analysis]
75 Parsons S, Tran VL. The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations. J Pediatr Pharmacol Ther 2021;26:220-39. [PMID: 33833623 DOI: 10.5863/1551-6776-26.3.220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Cox A, Schmierer J, D'Angelo J, Smith A, Levenson D, Treanor J, Kim B, Dewhurst S. A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity. Viruses 2020;12:E1246. [PMID: 33142846 DOI: 10.3390/v12111246] [Reference Citation Analysis]
77 Woo EJ, Moro PL. Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system. Vaccine 2021;39:1812-7. [PMID: 33678452 DOI: 10.1016/j.vaccine.2021.02.052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
78 Fishman JA. The epidemiology of community-acquired respiratory viruses during the SARS-CoV-2 pandemic. Am J Transplant 2020;20:3680. [PMID: 33264503 DOI: 10.1111/ajt.16382] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Uyeki TM, Santoli J, Jernigan DB. Preparing for the 2020-2021 Influenza Season. JAMA 2020;324:2318-9. [PMID: 33136115 DOI: 10.1001/jama.2020.21849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Cáceres CJ, Cardenas-Garcia S, Jain A, Gay LC, Carnaccini S, Seibert B, Ferreri LM, Geiger G, Jasinskas A, Nakajima R, Rajao DS, Isakova-Sivak I, Rudenko L, Vincent AL, Davies DH, Perez DR. Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein. Vaccines (Basel) 2021;9:703. [PMID: 34198994 DOI: 10.3390/vaccines9070703] [Reference Citation Analysis]
81 Mcnally VV, Bernstein HH. The Effect of the COVID-19 Pandemic on Childhood Immunizations: Ways to Strengthen Routine Vaccination. Pediatr Ann 2020;49. [DOI: 10.3928/19382359-20201115-01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
82 Ellingson MK, Bednarczyk RA, O'Leary ST, Schwartz JL, Shapiro ED, Niccolai LM. Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework. J Behav Med 2022. [PMID: 35194726 DOI: 10.1007/s10865-022-00296-4] [Reference Citation Analysis]
83 Nakphook S, Patumanond J, Shrestha M, Prasert K, Chittaganpitch M, Mott JA, Praphasiri P. Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study. PLoS One 2021;16:e0253028. [PMID: 34106994 DOI: 10.1371/journal.pone.0253028] [Reference Citation Analysis]
84 Chantasrisawad N, Jantarabenjakul W, Anugulruengkitt S, Punrin S, Limsuwun K, Sawangsinth P, Phasomsap C, Sophonphan J, Pancharoen C, Puthanakit T. Immunogenicity of 2-dose pre-exposure rabies vaccine co-administered with quadrivalent influenza vaccine in children. Int J Infect Dis 2021;112:89-95. [PMID: 34547486 DOI: 10.1016/j.ijid.2021.09.025] [Reference Citation Analysis]
85 Bhugra P, Grandhi GR, Mszar R, Satish P, Singh R, Blaha M, Blankstein R, Virani SS, Cainzos-Achirica M, Nasir K. Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement. J Am Heart Assoc 2021;10:e019671. [PMID: 34315229 DOI: 10.1161/JAHA.120.019671] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Zhou Y, Niu M, Zhang D, Liu Z, Wu Q, Chen J, Zhang H, Zhang P, Pei J. Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity. Front Pharmacol 2021;12:648439. [PMID: 34177573 DOI: 10.3389/fphar.2021.648439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Becerra-Culqui TA, Getahun D, Chiu V, Sy LS, Tseng HF. Prenatal influenza vaccination or influenza infection and autism spectrum disorder in offspring. Clin Infect Dis 2022:ciac101. [PMID: 35174388 DOI: 10.1093/cid/ciac101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Abdullahi H, Elnahas A, Konje JC. Seasonal influenza during pregnancy. Eur J Obstet Gynecol Reprod Biol 2021;258:235-9. [PMID: 33476926 DOI: 10.1016/j.ejogrb.2021.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Maniar YM, Al-Abdouh A, Michos ED. Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis. Curr Cardiol Rep 2022. [PMID: 35876953 DOI: 10.1007/s11886-022-01748-8] [Reference Citation Analysis]
90 Arreciado Marañón A, Fernández-Cano MI, Montero-Pons L, Feijoo-Cid M, Reyes-Lacalle A, Cabedo-Ferreiro RM, Manresa-Domínguez JM, Falguera-Puig G. Knowledge, Perceptions, Attitudes and Practices of Midwives Regarding Maternal Influenza and Pertussis Vaccination: A Qualitative Study. Int J Environ Res Public Health 2022;19:8391. [PMID: 35886242 DOI: 10.3390/ijerph19148391] [Reference Citation Analysis]
91 Lin CY, Yang ZS, Wang WH, Urbina AN, Lin YT, Huang JC, Liu FT, Wang SF. The Antiviral Role of Galectins toward Influenza A Virus Infection-An Alternative Strategy for Influenza Therapy. Pharmaceuticals (Basel) 2021;14:490. [PMID: 34065500 DOI: 10.3390/ph14050490] [Reference Citation Analysis]
92 Lu Y, Wang Y, Shen C, Luo J, Yu W. Decreased Incidence of Influenza During the COVID-19 Pandemic. IJGM 2022;Volume 15:2957-62. [DOI: 10.2147/ijgm.s343940] [Reference Citation Analysis]
93 Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, Cohen C, Fry AM. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. Am J Transplant 2020;20:3681-5. [PMID: 33264506 DOI: 10.1111/ajt.16381] [Cited by in Crossref: 78] [Cited by in F6Publishing: 52] [Article Influence: 39.0] [Reference Citation Analysis]
94 Krishnarajah G, Divino V, Postma MJ, Pelton SI, Anupindi VR, DeKoven M, Mould-Quevedo J. Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018-19 Influenza Season in the United States. Vaccines (Basel) 2021;9:80. [PMID: 33498724 DOI: 10.3390/vaccines9020080] [Reference Citation Analysis]
95 Moro PL, Marquez P. Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020. Vaccine 2021;39:678-81. [PMID: 33358703 DOI: 10.1016/j.vaccine.2020.12.045] [Reference Citation Analysis]
96 Proaños NJ, Reyes LF, Bastidas A, Martín-Loeches I, Díaz E, Suberviola B, Moreno G, Bodí M, Nieto M, Estella A, Sole-Violán J, Curcio D, Papiol E, Guardiola J, Rodríguez A; on behalf GETGAG SEMICYUC Working Group. Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza. Med Intensiva 2021:S0210-5691(21)00118-2. [PMID: 34175139 DOI: 10.1016/j.medin.2021.05.013] [Reference Citation Analysis]
97 Habighorst KR, Cillessen LM, Taylor HM, Reed JJ, Gubbins PO. Exploring strategies to increase college students' motivation to receive their annual influenza vaccine. J Am Coll Health 2022;:1-7. [PMID: 35166641 DOI: 10.1080/07448481.2022.2032092] [Reference Citation Analysis]
98 Frenkel LD. The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better? Allergy Asthma Proc 2021;42:378-85. [PMID: 34474707 DOI: 10.2500/aap.2021.42.210065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
99 Ledlie S, Gandhi-Banga S, Shrestha A, Mallett Moore T, Khromava A. Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry. Influenza Other Respir Viruses 2021. [PMID: 34520127 DOI: 10.1111/irv.12897] [Reference Citation Analysis]
100 Zhang D, Cui Q, Xu J, Cai J, Lu X, Yang Y. Factors related with COVID-19 vaccination willingness among outpatients in China. Hum Vaccin Immunother 2021;:1-6. [PMID: 34348592 DOI: 10.1080/21645515.2021.1954441] [Reference Citation Analysis]
101 Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, Kniss K, Burns E, Rowe T, Foust A, Jasso G, Merced-Morales A, Davis CT, Jang Y, Jones J, Daly P, Gubareva L, Barnes J, Kondor R, Sessions W, Smith C, Wentworth DE, Garg S, Havers FP, Fry AM, Hall AJ, Brammer L, Silk BJ. Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep 2021;70:1013-9. [PMID: 34292924 DOI: 10.15585/mmwr.mm7029a1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
102 Chow EJ, Beigi RH, Riley LE, Uyeki TM. Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy. Open Forum Infect Dis 2021;8:ofab138. [PMID: 34189160 DOI: 10.1093/ofid/ofab138] [Reference Citation Analysis]
103 Wodi AP, Ault K, Hunter P, McNally V, Szilagyi PG, Bernstein H. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2021. MMWR Morb Mortal Wkly Rep 2021;70:189-92. [PMID: 33571172 DOI: 10.15585/mmwr.mm7006a1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
104 Gkentzi D, Aggelopoulos K, Karatza A, Sinopidis X, Dimitriou G, Fouzas S. Influenza vaccination among caregivers and household contacts of children with asthma. Vaccine 2021;39:2331-4. [PMID: 33775437 DOI: 10.1016/j.vaccine.2021.03.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, Becker ML, Cron RQ, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Kimura Y, Lee T, Murphy K, Nigrovic PA, Ombrello MJ, Rabinovich CE, Tesher M, Twilt M, Klein-Gitelman M, Barbar-Smiley F, Cooper AM, Edelheit B, Gillispie-Taylor M, Hays K, Mannion ML, Peterson R, Flanagan E, Saad N, Sullivan N, Szymanski AM, Trachtman R, Turgunbaev M, Veiga K, Turner AS, Reston JT. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis Rheumatol 2022;74:570-85. [PMID: 35233961 DOI: 10.1002/art.42036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
106 Marcus RE, Kolade VO. Influenza Vaccination During COVID-19 in a Rural Community: A Cross-sectional Survey. J Community Health 2021. [PMID: 34647201 DOI: 10.1007/s10900-021-01036-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Chuey MR, Hung MC, Srivastav A, Lu PJ, Nguyen KH, Williams WW, Lainz AR. Influenza vaccination coverage among adults by nativity, race/ethnicity, citizenship, and language of the interview - United States, 2012-2013 through 2017-2018 influenza seasons. Am J Infect Control 2022;50:497-502. [PMID: 34520788 DOI: 10.1016/j.ajic.2021.09.003] [Reference Citation Analysis]
108 Lee EJ, Kwon OD, Kim SJ. Influenza Vaccination Status and Its Affecting Factors among Stroke Survivors: Findings from the Korea National Health and Nutrition Examination Survey. Vaccines (Basel) 2021;9:763. [PMID: 34358179 DOI: 10.3390/vaccines9070763] [Reference Citation Analysis]
109 Wautlet AJ, Patel PD, Chavez P, Codispoti CD. Influenza epidemics: The role of allergists-immunologists. Ann Allergy Asthma Immunol 2021;126:350-6. [PMID: 33259922 DOI: 10.1016/j.anai.2020.11.012] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 O'Halloran AC, Holstein R, Cummings C, Daily Kirley P, Alden NB, Yousey-Hindes K, Anderson EJ, Ryan P, Kim S, Lynfield R, McMullen C, Bennett NM, Spina N, Billing LM, Sutton M, Schaffner W, Talbot HK, Price A, Fry AM, Reed C, Garg S. Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019. JAMA Netw Open 2021;4:e2121880. [PMID: 34427679 DOI: 10.1001/jamanetworkopen.2021.21880] [Reference Citation Analysis]
111 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S46-59. [PMID: 34964869 DOI: 10.2337/dc22-S004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
112 Green I, Ashkenazi S, Merzon E, Vinker S, Golan-Cohen A. The association of previous influenza vaccination and coronavirus disease-2019. Hum Vaccin Immunother 2021;17:2169-75. [PMID: 33377817 DOI: 10.1080/21645515.2020.1852010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
113 Bhatt AS, Vardeny O, Udell JA, Joseph J, Kim K, Solomon SD. Influenza vaccination: a 'shot' at INVESTing in cardiovascular health. Eur Heart J 2021;42:2015-8. [PMID: 33748833 DOI: 10.1093/eurheartj/ehab133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
114 Kohl-Heckl WK, Schröter M, Dobos G, Cramer H. Complementary medicine use and flu vaccination - A nationally representative survey of US adults. Vaccine 2021;39:5635-40. [PMID: 34419302 DOI: 10.1016/j.vaccine.2021.08.017] [Reference Citation Analysis]
115 Bartley JM, Cadar AN, Martin DE. Better, Faster, Stronger: mRNA Vaccines Show Promise for Influenza Vaccination in Older Adults. Immunol Invest 2021;50:810-20. [PMID: 33830864 DOI: 10.1080/08820139.2021.1909617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, Fry AM. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season. MMWR Recomm Rep 2021;70:1-28. [PMID: 34448800 DOI: 10.15585/mmwr.rr7005a1] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
117 Hageman JR. Current Status of the COVID-19 Pandemic, Influenza and COVID-19 Together, and COVID-19 Viral Variants. Pediatr Ann 2020;49:e448-9. [PMID: 33170289 DOI: 10.3928/19382359-20201014-01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Radhakrishnan L, Stein Z, DeVies J, Smith A, Sheppard M, Hartnett KP, Kite-Powell A, Adjemian J, Rodgers LE. Syndromic surveillance of vaccine-associated adverse events in U.S. emergency departments. Vaccine 2021;39:4250-5. [PMID: 34167835 DOI: 10.1016/j.vaccine.2021.06.030] [Reference Citation Analysis]
119 Chang A, Ellingson MK, Flowers CR, Bednarczyk RA. Influenza Vaccination Rates Among Patients With a History of Cancer: Analysis of the National Health Interview Survey. Open Forum Infect Dis 2021;8:ofab198. [PMID: 34322565 DOI: 10.1093/ofid/ofab198] [Reference Citation Analysis]
120 Clarke M, Mathew SM, Giles LC, Pena AS, Barr IG, Richmond PC, Marshall HS. A Prospective Study Investigating the Impact of Obesity on the Immune Response to the Quadrivalent Influenza Vaccine in Children and Adolescents. Vaccines 2022;10:699. [DOI: 10.3390/vaccines10050699] [Reference Citation Analysis]
121 Maeda T, Sasaki H, Togawa A, Tanaka T, Arima H, Takata T, Takamatsu Y. Surveillance of the current situation regarding influenza vaccination according to medical oncologists in Japan. Cancer Sci 2021;112:433-43. [PMID: 33215475 DOI: 10.1111/cas.14742] [Reference Citation Analysis]
122 Hu W, Sjoberg PA, DeMarcus LS, Robbins AS. Influenza Vaccine Effectiveness Estimates among US Department of Defense Adult Beneficiaries over Four Consecutive Influenza Seasons: A Test-Negative Design Study with Different Control Groups. Vaccines (Basel) 2021;10:58. [PMID: 35062721 DOI: 10.3390/vaccines10010058] [Reference Citation Analysis]
123 Houser KV, Chen GL, Carter C, Crank MC, Nguyen TA, Burgos Florez MC, Berkowitz NM, Mendoza F, Hendel CS, Gordon IJ, Coates EE, Vazquez S, Stein J, Case CL, Lawlor H, Carlton K, Gaudinski MR, Strom L, Hofstetter AR, Liang CJ, Narpala S, Hatcher C, Gillespie RA, Creanga A, Kanekiyo M, Raab JE, Andrews SF, Zhang Y, Yang ES, Wang L, Leung K, Kong WP, Freyn AW, Nachbagauer R, Palese P, Bailer RT, McDermott AB, Koup RA, Gall JG, Arnold F, Mascola JR, Graham BS, Ledgerwood JE; VRC 316 Study Team. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial. Nat Med 2022. [PMID: 35115706 DOI: 10.1038/s41591-021-01660-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
124 Weinberger B. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun Ageing 2021;18:38. [PMID: 34627326 DOI: 10.1186/s12979-021-00249-6] [Reference Citation Analysis]
125 Peterson CJ, Lee B, Nugent K. COVID-19 Vaccination Hesitancy among Healthcare Workers-A Review. Vaccines (Basel) 2022;10:948. [PMID: 35746556 DOI: 10.3390/vaccines10060948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Covin S, Rutherford GW. Coinfection, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and Influenza: An Evolving Puzzle. Clin Infect Dis 2021;72:e993-4. [PMID: 33277660 DOI: 10.1093/cid/ciaa1810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
127 Perego G, Vigezzi GP, Cocciolo G, Chiappa F, Salvati S, Balzarini F, Odone A, Signorelli C, Gianfredi V. Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis. Vaccines (Basel) 2021;9:998. [PMID: 34579235 DOI: 10.3390/vaccines9090998] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Martínez-Baz I, Trobajo-Sanmartín C, Arregui I, Navascués A, Adelantado M, Indurain J, Fresán U, Ezpeleta C, Castilla J. Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers. Vaccines (Basel) 2020;8:E611. [PMID: 33076405 DOI: 10.3390/vaccines8040611] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
129 Li K, Yu T, Seabury SA, Dor A. Trends and Disparities in the Utilization of Influenza Vaccines Among Commercially Insured US Adults During the COVID-19 Pandemic. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.03.058] [Reference Citation Analysis]
130 Suntronwong N, Vichaiwattana P, Wongsrisang L, Klinfueng S, Korkong S, Thongmee T, Wanlapakorn N, Poovorawan Y. Prevalence of antibodies against seasonal influenza A and B viruses among older adults in rural Thailand: A cross-sectional study. PLoS One 2021;16:e0256475. [PMID: 34460848 DOI: 10.1371/journal.pone.0256475] [Reference Citation Analysis]
131 Purandare CN, Preiss S, Kolhapure S, Sathyanarayanan S. Expert opinion on the way forward for improving maternal influenza vaccination in India. Expert Rev Vaccines 2021;20:773-8. [PMID: 34018897 DOI: 10.1080/14760584.2021.1932474] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, Becker ML, Cron RQ, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Kimura Y, Lee T, Murphy K, Nigrovic PA, Ombrello MJ, Rabinovich CE, Tesher M, Twilt M, Klein-Gitelman M, Barbar-Smiley F, Cooper AM, Edelheit B, Gillispie-Taylor M, Hays K, Mannion ML, Peterson R, Flanagan E, Saad N, Sullivan N, Szymanski AM, Trachtman R, Turgunbaev M, Veiga K, Turner AS, Reston JT. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis Care Res (Hoboken) 2022;74:505-20. [PMID: 35233989 DOI: 10.1002/acr.24839] [Reference Citation Analysis]